Technology Transfer: door opener for collaboration opportunities
With targeted technology transfer, PSI pursues the goal of strengthening the competitiveness and innovative strength of Swiss companies in particular through an active exchange between research and industry. New knowledge and findings from research should lead to new ideas, problem solutions and marketable innovations.
The technology transfer team at PSI represents the interface between research and third parties and is a door opener for collaborations with industry, SMEs or academic partners.
Araris Biotech AG is a spin-off company from the Paul Scherrer Institute (PSI) and ETH Zurich focusing on the commercialization of a novel antibody-drug conjugate (ADC)-linker technology.
At the this year’s edition of the TOP 100 Swiss Startup Award, where Switzerland’s best startups with the greatest potential are celebrated, Araris ranks TOP14!
It is now the fifth year in a row, starting 2019, that Araris is selected by a Jury of investors and startup experts.
What a great success for Araris, after positions 19 in 2022 and 11 in 2021.
We congratulate Philipp Spycher (CEO) and his team for this great achievement!